Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

283.20
Delayed Data
As of Apr 24
 -2.22 / -0.78%
Today’s Change
128.50
Today|||52-Week Range
349.08
+81.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Revenue and IncomeNet Revenues405.4K445.4K445.4K445.0K
 
 
 
 
 
Depreciation And Amortization61.7K68.8K79.8K232.6K
 
 
 
 
 
 
Operating ExpensesGross Income----365.6K--
 
 
General Expenses31.5M22.8M36.4M35.3M
 
 
 
 
 
Research And Development25.9M14.9M27.4M23.7M
 
 
 
 
 
Total Operating Expenses31.6M22.9M36.5M35.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.2M-22.4M-36.1M-35.1M
 
 
 
 
 
Extraordinary Credit0.0055.8M0.00--
 
 
Extraordinary Charge-226.6M--0.00--
 
 
Other Expenses136.3K104.1K228.2K308.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-257.7M33.5M-35.8M-34.8M
 
 
 
 
 
Net Income-257.7M33.5M-35.8M-34.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS19.5M21.0M21.3M21.4M
 
 
 
 
 
Shares To Calculate EPS Diluted19.5M22.2M21.3M21.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$13.21$1.51-$1.69-$1.63
 
 
 
 
 
EPS Diluted-$13.21$1.51-$1.69-$1.63
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account